
BioVariance is a leading innovator in data-driven diagnostics, focusing on personalized medicine through the analysis of biomedical variance. Founded in 2013 by Dr. Josef Scheiber, the company has grown significantly, recognized among the top 100 most innovative medium-sized enterprises in Germany. BioVariance aims to improve patient health and quality of life by utilizing interdisciplinary analysis of medical data, particularly in the treatment of complex diseases like cancer. Their services include diagnostics of biomarkers, data analysis, and laboratory support, all aimed at enhancing the effectiveness of medical treatments. With a strong commitment to quality and customer satisfaction, BioVariance is positioned as a key player in the healthcare industry, leveraging advanced technologies and a dedicated team of experts.

BioVariance is a leading innovator in data-driven diagnostics, focusing on personalized medicine through the analysis of biomedical variance. Founded in 2013 by Dr. Josef Scheiber, the company has grown significantly, recognized among the top 100 most innovative medium-sized enterprises in Germany. BioVariance aims to improve patient health and quality of life by utilizing interdisciplinary analysis of medical data, particularly in the treatment of complex diseases like cancer. Their services include diagnostics of biomarkers, data analysis, and laboratory support, all aimed at enhancing the effectiveness of medical treatments. With a strong commitment to quality and customer satisfaction, BioVariance is positioned as a key player in the healthcare industry, leveraging advanced technologies and a dedicated team of experts.